Interaction between the cholinergic system and CRH in the modulation of spatial discrimination learning in mice

Brain Research

Volumn 906, Issue 1-2, 2001, Pages 46-59

  Steckler, Thomas ^a,b   Holsboer, Florian ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b JANSSEN RESEARCH FOUNDATION   (Belgium)

Author keywords

Acetylcholine; Corticotropin releasing hormone; CRH; Interaction; Learning; Memory; Spatial discrimination

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; MECAMYLAMINE; SCOPOLAMINE;

ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC RECEPTOR BLOCKING; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENTIATION; HORMONAL REGULATION; LEARNING; MALE; MAZE TEST; MOUSE; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; SPATIAL DISCRIMINATION; SWIMMING;

ACETYLCHOLINE; ANIMALS; BRAIN; CHOLINERGIC FIBERS; CORTICOTROPIN-RELEASING HORMONE; DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; MAZE LEARNING; MECAMYLAMINE; MICE; MICE, INBRED C57BL; MUSCARINIC ANTAGONISTS; NEURONS; NICOTINIC ANTAGONISTS; REACTION TIME; SCOPOLAMINE; SPACE PERCEPTION; TOUCH;

EID: 0035816387     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)02555-0     Document Type: Article

References (72)

1. Conditioned and unconditioned stimuli increase frontal cortical and hippocampal acetylcholine release: Effects of novelty, habituation, and fear
2. Excitotoxic lesions disrupt allocentric spatial learning in mice: Effects of strain and task demands
3. Displacement of corticotropin releasing factor from its binding protein as a possible treatment for Alzheimer's disease
4. Sex differences in learning and memory in mice: Effects of sequence of testing and cholinergic blockade
5. Hippocampal cholinergic blockade enhances hypothalamic-pituitary-adrenal responses to stress
6. Do centrally administered neuropeptides access cognate receptors?: An analysis in the central corticotropin-releasing factor system
7. Effect of cholinergic agonists and antagonists on rat hypothalamic corticotropin-releasing hormone secretion in vitro
8. Effects of novelty and pain on behavior and hippocampal extracellular ACh levels in male and female rats
9. 1 receptor mRNA expression
10. Immunocytochemical distribution of corticotropin-releasing hormone receptor type-1 (CRF1)-like immunoreactivity in the mouse brain: Light microscopic analysis using an antibody directed against the C-terminus
11. Noradrenergic mediation of the memory-enhancing effect of corticotropin-releasing factor in the locus coeruleus of rats
12. Rivastigmine, a brain-selective acetylcholinesterase inhibitor, ameliorates cognitive and motor deficits induced by closed-head injury in the mouse
13. Effects of concomitant nicotinic and muscarinic blockade on spatial memory disturbance in rats are purely additive. Evidence from the Morris water task
14. Selective loss of cholinergic neurons in Alzheimer's disease
15. Neuropeptide abnormalities in patients with early Alzheimer's disease
16. Corticotropin-releasing factor administered centrally, but not peripherally, stimulates hippocampal acetylcholine release
17. Prenatal stress enhances stress- and corticotropin-releasing factor-induced stimulation of hippocampal acetylcholine release
18. Effects of systemic and intracerebroventricular administration of mecamylamine, a nicotinic cholinergic antagonist, on spatial memory in rats
19. Increased corticotropin-releasing factor receptors in rat cerebral cortex following chronic atropine treatment
20. Reciprocal changes in corticotropin-releasing factor immunoreactivity and CRF receptors in cerebral cortex of Alzheimer's disease
21. Abnormalities in corticotropin-releasing hormone (CRH) in Alzheimer's disease and other human disorders
22. The role of the septal nuclei in the release of acetylcholine from the hippocampus of freely moving rats during sensory stimulation and running
23. Physiological and behavioral responses to corticotropin-releasing factor administration: Is CRF a mediator of anxiety or stress responses?
24. The role of the dorsal hippocampal serotonergic and cholinergic systems in the modulation of anxiety
25. Adrenocorticotropin response and nicotine-induced norepinephrine secretion in the rat paraventricular nucleus are mediated through brainstem receptors
26. Stress induced activation of the hippocampal cholinergic system and the pituitary adrenocortical axis
27. Learning impairment in transgenic mice with central over expression of corticotropin-releasing factor
28. Enhancement of performance in multiple learning tasks by corticotropin-releasing factor-binding protein ligand inhibitors
29. Effects of U-50,488H on scopolamine-, mecamylamine- and dizocilpine-induced learning and memory impairment in rats
30. The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety
31. CRF increases protein phosphorylation and enhances retention performance in rats
32. Changes in brain dopmaine and acetylcholine release during and following stress are independent of the pituitary-adrenocortical axis
33. Increases in hippocampal and frontal cortical acetylcholine release associated with presentation of sensory stimuli
34. Is cholinergic sensitivity a genetic marker for the affective disorders?
35. Regulation of corticotropin-releasing factor messenger RNA by nicotine in an immortalized amygdalar cell line
36. Changes in hippocampal theta following intrahippocampal corticotropin-releasing hormone (CRH) infusions in the rat
37. Effects of noise on high-affinity choline uptake in the frontal cortex and hippocampus of the rat are blocked by intracerebroventricular injection of corticotropin-releasing factor antagonist
38. Hippocampal CRF, NE, and NMDA system interactions in memory processing in the rat
39. Effects of nicotinic receptor blocker mecamylamine on radial-arm maze performance in rats
40. Catecholamines mediate nicotine-induced adrenocroticotropin secretion via alpha-adrenergic receptors
41. Nicotine activation of CRH neurons in extrahypothalamic regions of the rat brain
42. PRE-084, a sigma selective PCP derivative, attenuates MK-801-induced impairment of learning in mice
43. Effects of nucleus basalis lesions on cerebral cortical concentrations of corticotropin-releasing hormone (CRH)-like immunoreactivity in the rat
44. Differential effects of scopolamine and mecamylamine on working and reference memory in the rat
45. Alzheimer's disease and the cholinergic system: An introduction to clinical pharmacological research
46. Effects of acetylcholine on corticotropin-releasing factor gene expression in the hypothalamic paraventricular nucleus of conscious rats
47. Identification and characterization of muscarinic receptors potentiating the stimulation of adenylyl cyclase activity by corticotropin releasing hormone in membranes of rat frontal cortex
48. Central nervous system cardiovascular actions of CRF in sinuaortic-denervated rats
49. Effects of selection delays on radial maze performance: Acquisition and effects of scopolamine
50. The cholinergic hypothesis - 10 Years on
51. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia
52. Scopolamine impairs spatial working memory in the radial maze: An analysis by error type and arm choice
53. Modulation of learning and anxiety by corticotropin-releasing factor (CRF) and stress: Differential roles of CRF receptors 1 and 2
54. A reappraisal of the functions of the nucleus basalis of Meynert
55. Effects of concurrent manipulations of nicotinic and muscarinic receptors on spatial and passive avoidance learning
56. Pharmacological consequences of cholinergic plus serotonergic manipulations
57. Cognitive enhancers in theory and practice: Studies of the cholinergic hypothesis of cognitive deficits in Alzheimer's disease
58. Galanin microinjected into the medial septum inhibits scopolamine-induced acetylcholine overflow in the rat ventral hippocampus
59. Memory following cholinergic (NBM) and noradrenergic (DNAB) lesions made singly or in combination: Potentiation of disruption by scopolamine
60. Detection of corticotropin-releasing hormone receptor 1 immunoreactivity in cholinergic, dopaminergic and noradrenergic neurons of the basal forebrain and brainstem nuclei-potential implication for arousal and attention
61. The effects of intrahippocampal scopolamine infusions on anxiety in rats as measured by the black-white box test
62. Muscarinic antagonists are anxiogenic in rats tested in the black-white box
63. Corticotropin-releasing hormone receptor subtypes and emotion
64. Cholinergic lesions by 192 IgG-saporin and short-term recognition memory: Role of the septohippocampal projection
65. The role of serotonergic-cholinergic interactions in the mediation of cognitive behaviour
66. Recognition memory in rats. III. Neurochemical substrates
67. Disrupted allocentric but preserved egocentric spatial learning in transgenic mice with impaired glucocorticoid receptor function
68. Effects of various neurotransmitters and neuropeptides on the release of corticotropin-releasing hormone from the rat cortex in vitro
69. The modulation of neurosteroids of the scopolamine-induced learning impairment in mice involves an interaction with sigma1 (sigma1) receptors
70. Selective muscarinic antagonists differentially affect in vivo acetylcholine release and memory performances of young and aged rats
71. Effects of nicotinic agonists and antagonists on spatial working memory in normal adult and aged rats